1)(社)日本アイソトープ協会医学薬学部会ポジトロン核医学利用専門委員会:ポジトロン核医学利用専門委員会が成熟技術として認定した放射性薬剤の基準(2009年改定).Radioisotopes 58:221-245,2009
2)(社)日本アイソトープ協会医学薬学部会ポジトロン核医学利用専門委員会:「ポジトロン核医学利用専門委員会が成熟技術として認定した放射性薬剤の基準(2009年改定)」に関する解説.Radioisotopes 58:247-289,2009
Phelps ME(ed);PET:molecular imaging and its biological applications. New York, Springer-Verlag, 2004, pp1-124
4)Shibuya K, Yoshida E, Nishikido F, et al:Annihilation photon acollinearity in PET:volunteer and phantom FDG studies. Phys Med Biol 52:5249-5261, 2007
5)Defrise M:A factorization method for the 3D X-ray transform. Inverse Problems 11:983-994, 1995
6)Defrise M, Kinahan PE, Townsend DW, et al:Exact and approximate rebinning algorithms for 3-D PET data. IEEE Trans Med Imag 16:145-158, 1997
7)Townsend DW, Beyer T:A combined PET/CT scanner:the path to true image fusion. Br J Radiol 75:S24-30, 2002
8)Antoch G, Saoudi N, Kuehl H, et al:Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography(FDG-PET/CT)for tumor staging in solid tumors:comparison with CT and PET. J Clin Oncol 22:4357-4368, 2004
9)Reske SN, Grillenberger KG, Glatting G, et al:Overexpression of glucose transporter 1 and increased FDG uptake in pancreatic carcinoma. J Nucl Med 38:1344-1348, 1997
F-FDG PET/CT for image-guided and intensity-modulated radiotherapy. J Nucl Med 50:1655-1665, 2009
C-L-methionine positron emission tomography in the clinical management of cerebral gliomas. Mol Imaging Biol 10:1-18, 2008
12)平成20年厚生労働省告示第59号.
13)Inadama N, Murayama H, Watanabe M, et al:Performance of a PET detector with a 256ch flat panel PS-PMT. IEEE Trans Nucl Sci 51:58-62, 2004
14)山口慶一郎:PET診断における被曝管理.クリニカルPRTの最前線.51-56,先端医療技術研究所,2004
Proceedings of the First International Workshop on Time-of-Flight Positron Tomography. IEEE Computer Society, pp101-108, 1982
16)Yamaya T, Inaniwa T, Minohara S, et al:A proposal of an open PET geometry. Phys Med Biol 53:757-773, 2008